Teva to appeal $356m compensation ruling against claims they were responsible for infecting a patient with hepatitis C

[Guest guest]

http://www.globes.co.il/serveen/globes/docview.asp?did=1000628263 & fid=1725

Teva to appeal $356m compensation ruling

Alan Dershowitz will defend Teva and Baxter against claims they were responsible

for infecting a patient with hepatitis C.

6 March 11 19:55, Shiri Habib-Valdhorn

Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA; TASE:TEVA) is to appeal a US

court ruling from last May awarding $356 million to a hepatitis C sufferer who

used the company's medication.

Teva and Baxter Corporation, which distributed the drug, have filed a petition

with the Nevada Supreme Court. In addition to the $356 million Teva is being

ordered to pay the plaintiff Henry Channin, Baxter has been ordered to pay a

further $144 million.

Renowned defense attorney Alan Dershowitz is to represent Teva and Baxter in the

appeal. Teva and Baxter will argue that the court held them responsible without

the prosecution proving that it was the drug that harmed the plaintiff. Teva and

Baxter also claim that there were legal errors in the court's decision.

Teva has already been asked to deposit $580 million to serve as a guarantee

until the court case ends.

The case centers around Teva's propofol drug which is given to sedate patients

prior to surgery. In the summer of 2009, Teva recalled batches of drugs

including propofol which were discovered to be contaminated at a production line

in California. This medication was also found in the home of the singer

after his death but Teva insisted that he did not possess one of the

potentially contaminated drugs.

Teva has reported that 200 suits have been filed against the company by patients

that took the drug. The patients all became infected with Hepatitis C after

reuse of the drug in contravention of the manufacturer's instructions.

Published by Globes, Israel business news - www.globes-online.com - on March 6,

2011

© Copyright of Globes Publisher Itonut (1983) Ltd. 2011

[Guest guest]

http://www.globes.co.il/serveen/globes/docview.asp?did=1000628263 & fid=1725

Teva to appeal $356m compensation ruling

Alan Dershowitz will defend Teva and Baxter against claims they were responsible

for infecting a patient with hepatitis C.

6 March 11 19:55, Shiri Habib-Valdhorn

Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA; TASE:TEVA) is to appeal a US

court ruling from last May awarding $356 million to a hepatitis C sufferer who

used the company's medication.

Teva and Baxter Corporation, which distributed the drug, have filed a petition

with the Nevada Supreme Court. In addition to the $356 million Teva is being

ordered to pay the plaintiff Henry Channin, Baxter has been ordered to pay a

further $144 million.

Renowned defense attorney Alan Dershowitz is to represent Teva and Baxter in the

appeal. Teva and Baxter will argue that the court held them responsible without

the prosecution proving that it was the drug that harmed the plaintiff. Teva and

Baxter also claim that there were legal errors in the court's decision.

Teva has already been asked to deposit $580 million to serve as a guarantee

until the court case ends.

The case centers around Teva's propofol drug which is given to sedate patients

prior to surgery. In the summer of 2009, Teva recalled batches of drugs

including propofol which were discovered to be contaminated at a production line

in California. This medication was also found in the home of the singer

after his death but Teva insisted that he did not possess one of the

potentially contaminated drugs.

Teva has reported that 200 suits have been filed against the company by patients

that took the drug. The patients all became infected with Hepatitis C after

reuse of the drug in contravention of the manufacturer's instructions.

Published by Globes, Israel business news - www.globes-online.com - on March 6,

2011

© Copyright of Globes Publisher Itonut (1983) Ltd. 2011

[Guest guest]

http://www.globes.co.il/serveen/globes/docview.asp?did=1000628263 & fid=1725

Teva to appeal $356m compensation ruling

Alan Dershowitz will defend Teva and Baxter against claims they were responsible

for infecting a patient with hepatitis C.

6 March 11 19:55, Shiri Habib-Valdhorn

Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA; TASE:TEVA) is to appeal a US

court ruling from last May awarding $356 million to a hepatitis C sufferer who

used the company's medication.

Teva and Baxter Corporation, which distributed the drug, have filed a petition

with the Nevada Supreme Court. In addition to the $356 million Teva is being

ordered to pay the plaintiff Henry Channin, Baxter has been ordered to pay a

further $144 million.

Renowned defense attorney Alan Dershowitz is to represent Teva and Baxter in the

appeal. Teva and Baxter will argue that the court held them responsible without

the prosecution proving that it was the drug that harmed the plaintiff. Teva and

Baxter also claim that there were legal errors in the court's decision.

Teva has already been asked to deposit $580 million to serve as a guarantee

until the court case ends.

The case centers around Teva's propofol drug which is given to sedate patients

prior to surgery. In the summer of 2009, Teva recalled batches of drugs

including propofol which were discovered to be contaminated at a production line

in California. This medication was also found in the home of the singer

after his death but Teva insisted that he did not possess one of the

potentially contaminated drugs.

Teva has reported that 200 suits have been filed against the company by patients

that took the drug. The patients all became infected with Hepatitis C after

reuse of the drug in contravention of the manufacturer's instructions.

Published by Globes, Israel business news - www.globes-online.com - on March 6,

2011

© Copyright of Globes Publisher Itonut (1983) Ltd. 2011

[Guest guest]

http://www.globes.co.il/serveen/globes/docview.asp?did=1000628263 & fid=1725

Teva to appeal $356m compensation ruling

Alan Dershowitz will defend Teva and Baxter against claims they were responsible

for infecting a patient with hepatitis C.

6 March 11 19:55, Shiri Habib-Valdhorn

Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA; TASE:TEVA) is to appeal a US

court ruling from last May awarding $356 million to a hepatitis C sufferer who

used the company's medication.

Teva and Baxter Corporation, which distributed the drug, have filed a petition

with the Nevada Supreme Court. In addition to the $356 million Teva is being

ordered to pay the plaintiff Henry Channin, Baxter has been ordered to pay a

further $144 million.

Renowned defense attorney Alan Dershowitz is to represent Teva and Baxter in the

appeal. Teva and Baxter will argue that the court held them responsible without

the prosecution proving that it was the drug that harmed the plaintiff. Teva and

Baxter also claim that there were legal errors in the court's decision.

Teva has already been asked to deposit $580 million to serve as a guarantee

until the court case ends.

The case centers around Teva's propofol drug which is given to sedate patients

prior to surgery. In the summer of 2009, Teva recalled batches of drugs

including propofol which were discovered to be contaminated at a production line

in California. This medication was also found in the home of the singer

after his death but Teva insisted that he did not possess one of the

potentially contaminated drugs.

Teva has reported that 200 suits have been filed against the company by patients

that took the drug. The patients all became infected with Hepatitis C after

reuse of the drug in contravention of the manufacturer's instructions.

Published by Globes, Israel business news - www.globes-online.com - on March 6,

2011

© Copyright of Globes Publisher Itonut (1983) Ltd. 2011